Since increased serum ALT, in particular, occurs predominantly during NAFL and NASH (43), this parameter is suitable for the measurement of liver injury in both human and NAFLD animal models. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.